These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 2135644)
1. Alteration of natural killer cell subsets (two color analysis) and their activity in peripheral blood in inflammatory bowel disease. Hirata I; Hayashi K; Asada S; Miyoshi H; Iwakoshi K; Ohshiba S Bull Osaka Med Coll; 1990 Nov; 36(1-2):47-55. PubMed ID: 2135644 [TBL] [Abstract][Full Text] [Related]
2. Natural killer cell activity in patients with inflammatory bowel disease. Egawa S; Hiwatashi N J Clin Lab Immunol; 1986 Aug; 20(4):187-92. PubMed ID: 3093683 [TBL] [Abstract][Full Text] [Related]
3. Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease. Brown TE; Bankhurst AD; Strickland RG J Clin Lab Immunol; 1983 Jul; 11(3):113-7. PubMed ID: 6224936 [TBL] [Abstract][Full Text] [Related]
4. A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases. Shibatomi K; Ida H; Yamasaki S; Nakashima T; Origuchi T; Kawakami A; Migita K; Kawabe Y; Tsujihata M; Anderson P; Eguchi K Arthritis Rheum; 2001 Apr; 44(4):884-92. PubMed ID: 11315928 [TBL] [Abstract][Full Text] [Related]
5. Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells. Hirofuji H; Kakumu S; Fuji A; Ohtani Y; Murase K; Tahara H Clin Exp Immunol; 1987 May; 68(2):348-56. PubMed ID: 2820634 [TBL] [Abstract][Full Text] [Related]
6. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases. Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331 [TBL] [Abstract][Full Text] [Related]
7. Characterization of peripheral natural killer cells in primary Sjögren's syndrome: impaired NK cell activity and low NK cell number. Izumi Y; Ida H; Huang M; Iwanaga N; Tanaka F; Aratake K; Arima K; Tamai M; Kamachi M; Nakamura H; Origuchi T; Kawakami A; Anderson P; Eguchi K J Lab Clin Med; 2006 May; 147(5):242-9. PubMed ID: 16697772 [TBL] [Abstract][Full Text] [Related]
8. Natural killer activity and antibody-dependent cell-mediated cytotoxicity in primary glomerular diseases. Dohi K; Yamada H; Takai M; Fujii Y; Ishikawa H Clin Nephrol; 1987 Jan; 27(1):11-4. PubMed ID: 3493102 [TBL] [Abstract][Full Text] [Related]
9. Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect. Ginsburg CH; Dambrauskas JT; Ault KA; Falchuk ZM Gastroenterology; 1983 Oct; 85(4):846-51. PubMed ID: 6884709 [TBL] [Abstract][Full Text] [Related]
10. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood. Auer IO; Ziemer E; Sommer H Clin Exp Immunol; 1980 Oct; 42(1):41-9. PubMed ID: 7460390 [TBL] [Abstract][Full Text] [Related]
11. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease. Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of diminished natural killer cell activity in pregnant women and neonates. Baley JE; Schacter BZ J Immunol; 1985 May; 134(5):3042-8. PubMed ID: 3980989 [TBL] [Abstract][Full Text] [Related]
13. Leukocyte subpopulations and natural killer activity in endometriosis. Iwasaki K; Makino T; Maruyama T; Matsubayashi H; Nozawa S; Yokokura T Int J Fertil Menopausal Stud; 1993; 38(4):229-34. PubMed ID: 8401682 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic expression of natural killer cell associated membrane antigens in patients with chronic liver disease and hepatocellular carcinoma. Kakumu S; Hirofuji H; Fuji A; Tahara H; Yoshioka K J Clin Lab Immunol; 1988 May; 26(1):29-32. PubMed ID: 2846843 [TBL] [Abstract][Full Text] [Related]
15. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets. Lebow LT; Jewett A; Bonavida B J Immunol; 1993 Jan; 150(1):320-9. PubMed ID: 8417130 [TBL] [Abstract][Full Text] [Related]
16. Elevated natural killer (NK) cytotoxicity of mononuclear leucocytes from splenectomized patients: increase in Leu-7+ and Leu-11+ leucocytes. Ferrante A; Kiroff GK; Drew PA Clin Exp Immunol; 1986 Apr; 64(1):173-80. PubMed ID: 3731525 [TBL] [Abstract][Full Text] [Related]
17. Natural killer (NK) activity in patients with Hodgkin's disease before, during and after multiple-agent therapy. Frydecka I; Kotlarek-Haus S; Kuliszkiewicz-Janus M; Kuliczkowski K Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):407-14. PubMed ID: 2130805 [TBL] [Abstract][Full Text] [Related]
18. Natural killer (NKH-1+) cell number and activity in health and disease. Vranes Z; Uzarević B; Batinić D; Perić M; Poljaković Z; Maruśić M Med Lab Sci; 1990 Apr; 47(2):108-12. PubMed ID: 2381267 [TBL] [Abstract][Full Text] [Related]
19. [The effect of sera of breast cancer patients on NK cell activity]. Konjević G; Spuzić I Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436 [TBL] [Abstract][Full Text] [Related]
20. The effect of blood donation on natural killer activity in man. Lasek W; Plodziszewska M; Jakobisiak M J Clin Lab Immunol; 1987 Apr; 22(4):165-8. PubMed ID: 3612753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]